{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:52:19Z","timestamp":1780573939382,"version":"3.54.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.path.2022.02.010","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T19:54:40Z","timestamp":1655236480000},"page":"369-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Squamous and Glandular Epithelial Tumors of the Cervix"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4459-7019","authenticated-orcid":false,"given":"Simona","family":"Stolnicu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.path.2022.02.010_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J Clin"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib2","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.path.2022.02.010_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","article-title":"International ECA criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PGP.0000000000000132","article-title":"A rare case of HPV-negative cervical squamous carcinoma","volume":"34","author":"Casey","year":"2015","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.010_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1471-0528.13071","article-title":"HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis","volume":"122","author":"Rodriguez-Carunchio","year":"2015","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.path.2022.02.010_bib6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41379-019-0249-1","article-title":"HPV-negative tumors of the uterine cervix","volume":"32","author":"Nicolas","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib7","series-title":"Tumours of the uterine cervix. W. C. o. T. E. B. F. g. tumours","author":"Herrington","year":"2020"},{"key":"10.1016\/j.path.2022.02.010_bib8","series-title":"WHO classification of tumors of female reproductive organs","author":"Kurman","year":"2014"},{"key":"10.1016\/j.path.2022.02.010_bib9","author":"Authors listed"},{"issue":"1732","key":"10.1016\/j.path.2022.02.010_bib10","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0273","article-title":"Oncogenic human papillomaviruses","volume":"372","author":"McBride","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"10.1016\/j.path.2022.02.010_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/path.4405","article-title":"Pathogenic role of the eight probably\/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer","volume":"234","author":"Halec","year":"2014","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.path.2022.02.010_bib12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0b013e31828b6be4","article-title":"The occasional role of low-risk human papillomaviruses 6, 11, 42, 44 and 70 in anogenital carcinoma defined by laser capture microdissection\/PCR methodology: results from a global study","volume":"37","author":"Guimera","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12967-014-0255-5","article-title":"TP53 and PIK3CA gene mutations in adenocarcinoma, SCC and high-grade intraepithelial neoplasia of the cervix","volume":"12","author":"Tornesello","year":"2014","journal-title":"J Transl Med"},{"issue":"7645","key":"10.1016\/j.path.2022.02.010_bib14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","author":"Burk","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.path.2022.02.010_bib15","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ygyno.2005.01.016","article-title":"Lymphoepithelioma-like carcinoma of the uterine cervix: Absence of Epstein-Barr virus, but presence of multiple human papillomavirus infection","volume":"197","author":"Bais","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PGP.0b013e31818fb0a9","article-title":"Does Epstein-Barr virus play a role in lymphoepithelioma-like carcinoma of the uterine cervix?","volume":"28","author":"Chao","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib17","first-page":"73","article-title":"SCC of the uterine cervix- a review with emphasis on prognostic factors and unusual variants","volume":"7","author":"Robert","year":"1990","journal-title":"Sem Diagn Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0090-8258(03)00270-1","article-title":"A case report of multicentric verrucous carcinoma of the female genital tract","volume":"90","author":"Yorganci","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previous treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","author":"Chung","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib20","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1200\/JCO.2017.74.5471","article-title":"Safety and efficacy of pembrolizumab in advanced, programmed death ligand 1-positive cervical cancer: results from the phase ib KEYNOTE-028 Trial","volume":"35","author":"Frenel","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1758834017708742","article-title":"Pembrolizumab in cervical cancer: latest evidence and clinical usefulness","volume":"9","author":"Borcoman","year":"2017","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"10.1016\/j.path.2022.02.010_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semdp.2011.08.008","article-title":"Issues and inconsistencies in the revised gynecologic staging systems","volume":"29","author":"Cole","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cjp2.98","article-title":"Towards developing a meaningful grading system for cervical SCC","volume":"4","author":"McCluggage","year":"2018","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.path.2022.02.010_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/PGP.0000000000000412","article-title":"Data set for the reporting of carcinomas of the cervix: Recommendations for the International Collaboration on Cancer Reporting (ICCR)","volume":"37","author":"McCluggage","year":"2018","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/cjp2.95","article-title":"Introducing a novel highly prognostic grading scgeme based on tumor budding and cell nest size for SCC of the utetine cervix","volume":"4","author":"Jesinghaus","year":"2018","journal-title":"J Pathol Clin Res"},{"issue":"9","key":"10.1016\/j.path.2022.02.010_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/PAS.0000000000001472","article-title":"Independent validation of tumor budding activity and cell nest size as determinants of patient outcome in squamous cell carcinoma of the uterine cervix","volume":"44","author":"Zare","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib27","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ygyno.2006.05.046","article-title":"Pattern of invasion is of prognostic value in surgically treated cervical cancer patients","volume":"103","author":"Horn","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.path.2022.02.010_bib28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human Papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib29","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/00000478-200110000-00013","article-title":"High differentiated keratinizing squamous cell carcinoma of the cervix. A rare locally aggresive tumor not associated with human papillomavirus or squamous intraepithelial lesion","volume":"25","author":"Morrison","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.010_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ijgc-00009577-200101000-00006","article-title":"The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University","volume":"11","author":"Pilch","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000001095","article-title":"International endocervical adenocarcinoma criteria and classification: validation and interobserver reproducibility","volume":"43","author":"Hodgson","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2022.02.010_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00428-020-02770-3","article-title":"The evolving spectrum of ECA in situ (AIS)","volume":"476","author":"Stolnicu","year":"2020","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.path.2022.02.010_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/PAS.0000000000001245","article-title":"Micropapillary cervical adenocarcinoma: a clinicopathologic study of 44 cases","volume":"43","author":"Alvarado-Cabrero","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2022.02.010_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PGP.0000000000000357","article-title":"Factors predicting pelvic lymph node metastasis, relapse and disease outcome in pattern C endocervical adenocarcinomas","volume":"36","author":"Alvarado-Cabrero","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PAS.0000000000000543","article-title":"Invasive stratified mucin producing carcinoma and stratified mucin-producing intraepithelial lesion (SMILE): 15 cases presenting a spectrum of cervical neoplasia with description of a distinctive variant of invasive adenocarcinoma","volume":"40","author":"Lastra","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001485","article-title":"Invasive stratified mucinous carcinoma (iSMC) of the cervix often presents with high-risk features that are determinants of poor outcome: an international multicentric study","author":"Stolnicu","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2022.02.010_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/PGP.0000000000000680","article-title":"Trefoil Factor 2 (TFF2) as a Surrogate Marker for Endocervical Gastric-type Carcinoma","volume":"40","author":"Kiyokawa","year":"2021","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.path.2022.02.010_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00428-019-02739-x","article-title":"Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and M\u00fcllerian-type","volume":"476","author":"Asaka","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2022.02.010_bib39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/PAS.0000000000001090","article-title":"Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.path.2022.02.010_bib41","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.28288","article-title":"Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib42","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1158\/1078-0432.CCR-14-1837","article-title":"Genome analysis of latin American cervical cancer: frequent activation of the PIK3CA pathway","volume":"21","author":"Lou","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2022.02.010_bib43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12967-014-0255-5","article-title":"TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix","volume":"12","author":"Tornesello","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.path.2022.02.010_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.path.2022.02.010_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/gyno.2000.5731","article-title":"Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix","volume":"77","author":"Lacey","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib46","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cncr.11567","article-title":"Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix","volume":"98","author":"Lacey","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.path.2022.02.010_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAP.0000000000000216","article-title":"Gastric-type adenocarcinoma of the cervix: tumor with wide range of histologic appearance","volume":"26","author":"Pirog","year":"2018","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.mpdhp.2021.09.002","article-title":"Cervical cancer. What's new in classification, morphology, molecular findings and prognosis of glandular precursor and invasive lesions","author":"Stolnicu","year":"2021","journal-title":"Diagnostic Histopathology"},{"issue":"3","key":"10.1016\/j.path.2022.02.010_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/PAS.0000000000001212","article-title":"Hepatocytic Nuclear Factor-1-Beta (HNF-1beta), Estrogen and Progesterone receptors Expression in Arias-Stella Reaction","volume":"43","author":"Ip","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"10.1016\/j.path.2022.02.010_bib50","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/PGP.0000000000000751","article-title":"Tumor typing on endocervical adenocarcinoma: contemporary review and recommendations from the International Society of Gynecological Pathologists","volume":"40","author":"Stolnicu","year":"2021","journal-title":"Int J Gynecol Pathol"},{"issue":"suppl 1","key":"10.1016\/j.path.2022.02.010_bib51","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/PGP.0000000000000741","article-title":"Grading on endocervical adenocarcinomas: review of the literature and recommendation from the International Society of Gynecological Pathologists","volume":"40","author":"Talia","year":"2021","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.path.2022.02.010_bib52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/PGP.0b013e31829952c6","article-title":"Invasive ECA: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study","volume":"32","author":"Diaz De Vivar","year":"2013","journal-title":"Int J Gynecol Pathol"},{"issue":"suppl 1","key":"10.1016\/j.path.2022.02.010_bib53","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/PGP.0000000000000735","article-title":"The Silva pattern-based classification for HPV-associated invasive endocervical adenocarcinoma and the ditinction between in situ and invasive adenocarcinoma: relevant issues and recommendations from the International Society of Gynecological Pathologists","volume":"40","author":"Alvarado-Cabrero","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2018.04.570","article-title":"Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas but is irrelevant in adenocarcinomas unassociated with HPV","volume":"150","author":"Stolnicu","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PAS.0000000000000316","article-title":"Interobserver variability in the application of a proposed histologic subclassification of endocervical adenocarcinoma","volume":"39","author":"Paquette","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/modpathol.2016.86","article-title":"Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists","volume":"29","author":"Parra-Herran","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib57","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/modpathol.2016.94","article-title":"Pattern classification of endocervical adenocarcinoma: reproducibility and review of criteria","volume":"29","author":"Rutgers","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib58","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/PGP.0000000000000264","article-title":"Application of a Pattern-based Classification System for Invasive Endocervical Adenocarcinoma in Cervical Biopsy, Cone and Loop Electrosurgical Excision (LEEP) Material: Pattern on Cone and LEEP is Predictive of Pattern in the Overall Tumor","volume":"35","author":"Djordjevic","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib59","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/modpathol.2017.80","article-title":"Genomic abnormalities in invasive adenocarcinoma correlate with pattern of invasion: biologic and clinical implications","volume":"30","author":"Hodgson","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2018.09.013","article-title":"Independent validation of the prognostic significance of invasion patterns in endocercvical adenocarcinoma: pattern A predicts excellent survical","volume":"151","author":"Spaans","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/PAI.0000000000000915","article-title":"mTOR activation assessed by immunohistochemostry in cervical biopsies of HPV-associated endocervical adenocarcinomas (HPVA): correlation with Silva invasion patterns","author":"Segura","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"10.1016\/j.path.2022.02.010_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ijgc-2020-001893","article-title":"FIGO 2018 stage IB ECAs: a detailed international study of clinical outcomes informed by prognostic biomarkers, including human papillomavirus (HPV) status","volume":"31","author":"Stolnicu","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib63","unstructured":"Stolnicu S, Boros M, Hoang L, et al. Clinical Correlation of Silva Patterns of Invasion and 2019 FIGO Low-Stage (IA and IB1) in ECA (ECA). USCAP meeting abstract book 2021."},{"key":"10.1016\/j.path.2022.02.010_bib64","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/PAS.0b013e3181758831","article-title":"Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms","volume":"32","author":"Ronnett","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib65","series-title":"Clear cell carcinoma (CCC) of the cervix is a Human Pappilomavirus (HPV)-independent tumor associated with poor prognosis","author":"Stolnicu","year":"2021"},{"issue":"5","key":"10.1016\/j.path.2022.02.010_bib66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multiinstitutional study","volume":"45","author":"Pors","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.path.2022.02.010_bib68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.path.2022.02.010_bib70","first-page":"287","article-title":"The new (version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer","volume":"71","author":"Olawaiye","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.path.2022.02.010_bib71","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00428-018-2362-9","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer","volume":"472","author":"Cibula","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2022.02.010_bib72","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"issue":"suppl 1","key":"10.1016\/j.path.2022.02.010_bib73","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/PGP.0000000000000745","article-title":"Endocervical adenocarcinoma, gross examination and processing including intraoperative evaluation: recommendations from the International Society of Gynecological Pathologists","volume":"40","author":"Parra-Herran","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib74","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2005.05.026","article-title":"Risk grouping in stage IB squamous cell cervical carcinoma","volume":"99","author":"Van de Putte","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0090-8258(89)90070-X","article-title":"A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"35","author":"Delgado","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2013.716","article-title":"Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study","volume":"110","author":"Ryu","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib77","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1234::AID-CNCR6>3.0.CO;2-K","article-title":"Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes","volume":"80","author":"Samlal","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib78","first-page":"266","article-title":"The prognostic role of horizontal and circumferential tumor extend in cervical cancer: implications for the 2019 FIGO staging system","volume":"158","author":"Zyla","year":"2020","journal-title":"GynecolOncol"},{"key":"10.1016\/j.path.2022.02.010_bib79","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/1097-0142(19921015)70:8<2121::AID-CNCR2820700819>3.0.CO;2-S","article-title":"Microinvasive carcinoma of the cervix","volume":"70","author":"Sevin","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib80","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1525-1438.2000.00011.x","article-title":"Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases","volume":"10","author":"Elliott","year":"2000","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.path.2022.02.010_bib81","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/1097-0142(19920401)69:7<1750::AID-CNCR2820690717>3.0.CO;2-S","article-title":"Histopathologic Predictors of the Behavior of Surgically Treated Stage IB SCC of the Cervix. A Gynecologic Oncology Group Study","volume":"69","author":"Zaino","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2022.02.010_bib82","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<689::AID-CNCR11>3.0.CO;2-U","article-title":"The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen","volume":"82","author":"Obermair","year":"1998","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.path.2022.02.010_bib83","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/annonc\/mdg412","article-title":"Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis","volume":"14","author":"Morice","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/PGP.0000000000000269","article-title":"Multifocal FIGO stage IA1 squamous carcinoma of the cervix: Criteria for identification, staging and its good clinical outcome","volume":"35","author":"Day","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/PGP.0b013e31829040ce","article-title":"Multifocal FIGO stage IA1 cervical squamous carcimomas have an extremely good prognosis equivalent to unifocal lesions","volume":"33","author":"Mcllwaine","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib86","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ygyno.2018.10.007","article-title":"Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions","volume":"152","author":"Cibula","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib87","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ijgc-2018-000089","article-title":"Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial","volume":"29","author":"Guani","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.path.2022.02.010_bib88","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jmig.2013.12.095","article-title":"Sentinel lymph evaluation in women with cervical cancer","volume":"21","author":"Holman","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.path.2022.02.010_bib89","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/PGP.0000000000000758","article-title":"Tumor staging of endocervical adenocarcinoma: recommendations from the International Society of Gynecological Pathologists","volume":"40","author":"Park","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2022.02.010_bib90","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/02841868009130178","article-title":"Invasive SCC of the uterine cervix. I. Definition of parameters in a histopathologic malignancy grading system","volume":"19","author":"Stendahl","year":"1980","journal-title":"Acta Radiol Oncol"},{"key":"10.1016\/j.path.2022.02.010_bib91","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2005.10.004","article-title":"Ovarian metastasis in carcinoma of the uterine cervix","volume":"101","author":"Shimada","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918122000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:43:06Z","timestamp":1761748986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918122000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1875918122000204"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2022.02.010","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Squamous and Glandular Epithelial Tumors of the Cervix","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2022.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}